Vivo Opportunity Fund Holdings, L.P. - Sep 30, 2025 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Stock, no par value (DRUG)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Bright Minds Biosciences Inc. Common Stock, no par value
Symbol
DRUG
Shares outstanding
7.1M shares
Disclosed Ownership
454K shares
Ownership
6.4%
Form type
SCHEDULE 13G
Date filed
11/14/2025, 06:38 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 6.4% 454K 454K 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 6.4% 454K 454K 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.7% 47.4K 47.4K 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.7% 47.4K 47.4K 0 /s/ Kevin Dai Kevin Dai/Managing Member